ARCHIVES

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

This article is from The Cancer Letter archive.

Vol. 11 No. 47 | December 6, 1985

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops

August 28, 1987

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978